HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma.
Nakamura T, Hayashi T, Kimura Y, Kawakami H, Takahashi K, Ishiwatari H, Goto T, Motoya M, Yamakita K, Sakuhara Y, Ono M, Tanaka E, Omi M, Murakawa K, Iida T, Sakurai T, Haba S, Abiko T, Ito YM, Maguchi H, Hirano S; Hokkaido Pancreatic Cancer Study Group (HOPS).
Nakamura T, et al. Among authors: omi m.
Sci Rep. 2022 Jun 15;12(1):9966. doi: 10.1038/s41598-022-14094-0.
Sci Rep. 2022.
PMID: 35705607
Free PMC article.
Clinical Trial.